{
  "ticker": "HPC",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969899",
  "id": "02969899",
  "pages": 3,
  "price_sensitive": false,
  "date": "20250716",
  "time": "1644",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250716/pdf/06lvnrf5hy5z4r.pdf",
  "summary": "### **Summary of ASX Announcement (Form 603 \u2013 Initial Substantial Holder Notice)**  \n\n- **Substantial Holder:** J.A.F. Capital Pty Ltd (ACN: 607 525 360)  \n- **Company:** The Hydration Pharmaceuticals Company Limited (ACN: 620 385 677)  \n- **Voting Power Acquired:** **5.34%**  \n- **Total Shares Acquired:** **23,000,000 FPO** (fully paid ordinary shares)  \n- **Nature of Interest:** **Direct** ownership  \n- **Key Dates:** Acquisitions occurred between **24/03/2025** and **14/07/2025**  \n- **Consideration:** Mixed cash/non-cash (detailed in annexure; no single dominant transaction price disclosed).  \n\n**Material Implication:** New substantial holder (5%+) may signal strategic interest or influence in the company.",
  "usage": {
    "prompt_tokens": 1815,
    "completion_tokens": 193,
    "total_tokens": 2008,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-16T07:33:31.638735"
}